# A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia

> **NCT01568333** · PHASE2 · COMPLETED · sponsor: **Shandong University** · enrollment: 45 (actual)

## Conditions studied

- Immune Thrombocytopenia

## Interventions

- **DRUG:** Decitabine

## Key facts

- **NCT ID:** NCT01568333
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2017-10
- **Final completion:** 2018-08
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2018-08-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01568333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01568333, "A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01568333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*